FESARIUSTHERAPEUTICS INC
DermiSphere, a dermal replacement scaffold that regenerates full-thickness skin dermis through guided cellular infiltration and angiogenesis
Follows are private to you and power your alerts
Updated · fesariustherapeutics.com
- Sector
- Medtech
- Headquarters
- New York, NY
- Total capital
- $7.8M
- Federal grants
- $7.8M
- 13 awards · 2019–2025
- Rank in peer group#307 of 538
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 2 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · An Antimicrobial Dermal Regeneration Template for application in challenging wound environments$350K
- Federal grantHealth and Human S · Phase I · An advanced dermal regeneration scaffold for skin loss due to burn wounds$349K
- Federal grantHealth and Human S · Phase II · An Advanced Dermal Regeneration Scaffold for Reconstructive Surgery$954K
- Federal grantHealth and Human S · Phase II · An Advanced Dermal Regeneration Scaffold for Reconstructive Surgery$50K
- Federal grantHealth and Human S · Phase II · DermiSphere™: An Advanced Dermal Regeneration Scaffold for Reconstructive Surgery, CRP$400K
- Federal grantHealth and Human S · Phase II · An Advanced Dermal Regeneration Scaffold for Reconstructive Surgery$884K
- Federal grantHealth and Human S · Phase II · An Advanced Dermal Regeneration Scaffold for Reconstructive Surgery$884K
Show 6 earlier federal awards
- Federal grantHealth and Human S · Phase II · DermiSphere: An Advanced Dermal Regeneration Scaffold for Reconstructive Surgery, PHASE II$915K
- Federal grantHealth and Human S · Phase II · DermiSphere: An Advanced Dermal Regeneration Scaffold for Reconstructive Surgery, PHASE II$1.7M
- Federal grantHealth and Human S · Phase II · DermiSphereâÃÂâ: An Advanced Dermal Regeneration Scaffold for Reconstructive Surgery, PHASE II$765K
- Federal grantHealth and Human S · Phase I · FesariusTherapeutics Inc. I-Corps Program to Benefit the development and sales of its flagship product DermiSphere(tm)$55K
- Federal grantHealth and Human S · Phase I · FesariusTherapeutics Inc. I-Corps Program to Benefit the development and sales of its flagship product DermiSphere(tm)$279K
- Federal grantHealth and Human S · Phase I · DermiSphere™: An Advanced Dermal Regeneration Scaffold for Reconstructive Surgery$224K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 2- PendingBioengineered Scaffolds And Methods Of Making And Using The SameUSPTOApplication PCTUS2025060477
- PendingBioengineered Scaffolds And Methods Of Making And Using The SameUSPTOApplication 63735491
Related companies, and why
- KoKo Medical, Inc.Similar federal contract value in Medtech · null in contracts
- M2 TECHNOLOGIES LLCSimilar federal contract value in Medtech · null in contracts
- LUMICELL, INC.Similar federal contract value in Medtech · null in contracts
- SAUREUS, INC.Similar federal contract value in Medtech · null in contracts
- ADGERO BIOPHARMACEUTICALS HOLDINGS INCSimilar federal contract value in Medtech · null in contracts
- RIGHTAIR, LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .